【药物名称】Dihydrocalanolide A-(+), (+)-Dihydrocalanolide A, NSC-678323
化学结构式(Chemical Structure):
参考文献No.22140
标题:Calanolide antiviral cpds., compsns. and uses ther
作者:Boyd, M.R.; Cardellina, J.H. II; Gustafson, K.R.; McMahon, J.B.; Fuller, R.W.; Cragg, G.M.; Kashman, Y. (US Department of Health & Human Services)
来源:EP 0633887; JP 1996502948; JP 1996507311; US 5591770; WO 9320082; WO 9428000
合成路线图解说明:

1) The cyclization of phloroglucinol (I) with butyrylacetic acid ethyl ester (II) by means of concentrated sulfuric acid gives 5,7-dihydroxy-4-propyl-2H-1-benzopyran-2-one (III), which is condensed with propionyl chloride by means of AlCl3 in nitrobenzene, yielding the 8-propionyl derivative (V). The cyclization of (V) with 3-hydroxy-3-methylbuytyraldehyde dimethylacetal (VI) in refluxing pyridine affords the benzodipyran (VII), which is cyclized again with paraldehyde or acetaldehyde dimethylacetal by means of p-toluenesulfonic acid and trifluoroacetic acid in pyridine at 140 C to give a mixture of the diastereomeric racemates (VIII) and (IX), which are separated by column chromatography. The reduction of racemate (VIII) with NaBH4 /CeCl3 in ethanol yields a new mixture of the racemic hydroxy epimers (X) (racemic calanolide A) and (XI), which are separated by semipreparative HPLC. Racemic calanolide A (X) is finally submitted to optical resolution by semipreparative chiral HPLC.

合成路线图解说明:

Calanolide A (I), a compound isolated from the tropical tree Calophyllym lanigerum, was selectively hydrogenated at the 7,8-double bond employing PtO2 poisoned with NH4OH to afford the title compound.

参考文献No.534927
标题:Structure-activity modifications of the HIV-1 inhibitors (+)-calanolide A and (-)-calanolide B
作者:Galinis, D.L.; Fuller, R.W.; McKee, T.C.; Cardellina, J.H. II; Gulakowski, R.J.; McMahon, J.B.; Boyd, M.R.
来源:J Med Chem 1996,39(22),4507
合成路线图解说明:

Calanolide A (I), a compound isolated from the tropical tree Calophyllym lanigerum, was selectively hydrogenated at the 7,8-double bond employing PtO2 poisoned with NH4OH to afford the title compound.

Drug Information Express,Drug R&D,Chemical Database,Patent Search.
Copyright © 2006-2024 Drug Future. All rights reserved.Contact Us